Published in
The Lancet Oncology, The Lancet (Reed Elsevier)
Content
A parliamentary committee has asked the Indian Government to impose price caps on certain cancer medicines, citing concerns over affordability and access for patients. Currently, India enforces a 30% trade margin cap covering 42 essential anti-cancer drugs. The new recommendation seeks to expand this list to include cancer vaccines, immunotherapy, and oral chemotherapy. The committee also advised monitoring the quality of generic medicines, noting hesitancy among clinicians to prescribe them.
Karl Gruber
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0